Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Goodwill (2016)

Tenax Therapeutics' Goodwill history spans 2 years, with the latest figure at $11.3 million for Q3 2016.

  • On a quarterly basis, Goodwill changed N/A to $11.3 million in Q3 2016 year-over-year; TTM through Sep 2016 was $11.3 million, a N/A change, with the full-year FY2015 number at $11.3 million, changed N/A from a year prior.
  • Goodwill hit $11.3 million in Q3 2016 for Tenax Therapeutics, roughly flat from $11.3 million in the prior quarter.
  • Over the last five years, Goodwill for TENX hit a ceiling of $11.3 million in Q4 2015 and a floor of $11.3 million in Q4 2015.